Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine dose comparison for time to first pain after shoulder surgery
ACTRN12611000155998Phase 4Completed
- Sponsor
- Dr Michael Fredrickson
- Start
- Feb 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ropivacaine in postoperative pain (5 arms), sponsored by Dr Michael Fredrickson. Primary endpoint: Time to first pain. Started Feb 2011; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12611000155998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000155998.